Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421595
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421595
Drug Discovery Services Market Share, Size, Trends, Industry Analysis Report, By Type (Small molecules, Large Molecules) By End-Use; By Region; Segment Forecast, 2024 - 2032
PUBLISHED:
PAGES: 117 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global drug discovery services market size is expected to reach USD 64.08 Billion by 2032, according to a new study by Polaris Market Research. The "Drug Discovery Services Market Share, Size, Trends, Industry Analysis Report, By Type (Small molecules, Large Molecules) By End-Use; By Region; Segment Forecast report, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The process of searching for a substance suitable for treating and controlling diseases is known as drug discovery. Typically, the quest for a potential drug starts with a molecule displaying fascinating biological characteristics or interacting with a biological target known to play a role in the advancement of a disease.
Recent technological progress has transformed the landscape of drug discovery, elevating it to a realm of greater sophistication, precision, and increased time investment. In the past, drug development primarily relied on pinpointing the active constituents within traditional remedies, a prime example being the discovery of penicillin.
The pharmaceutical industry's relentless pursuit of innovative and effective therapeutics is prompting a significant increase in research and development (R&D) budgets. As the global disease burden continues to escalate, there is a growing call for new medications capable of addressing unmet medical needs. Consequently, pharmaceutical companies are increasingly motivated to augment their R&D investments in the quest for groundbreaking treatments. This heightened commitment, in turn, fuels a rising demand for drug discovery services.
The landscape of drug discovery research has evolved significantly due to advancements in scientific knowledge and technology. The emergence of genomics, proteomics, high-throughput screening, computational modeling, and other state-of-the-art tools has intricately transformed the process of identifying and developing new drug candidates. These breakthroughs necessitate substantial investments in specialized equipment, expertise, and infrastructure, consequently leading to an escalation in R&D expenditures.
The drug discovery services market underwent a profound transformation due to the COVID-19 pandemic, impacting multiple facets of the industry. This global health crisis intensified the spotlight on infectious diseases. The pressing demand for COVID-19 treatments and vaccines spurred substantial investments and collaborations within the realm of infectious disease research and development. Numerous providers of drug discovery services pivoted their focus toward the development of drugs and treatments designed specifically to combat the virus. This change led to a growing need for services related to identifying targets, optimizing leads, and conducting preclinical testing for infectious diseases.
Additionally, a study published in the National Library of Medicine in June 2021 highlighted the significant impact of coronary artery disease (CAD) on global health. CAD alone is responsible for approximately 610,000 deaths annually, accounting for an estimated one in four deaths and making it the foremost cause of mortality in the United States. With the incidence of CAD rising, there is a growing demand for effective coronary stent devices to address this pressing medical need. Consequently, this factor is projected to drive the demand for coronary stents throughout the forecast period.
Drug Discovery Services Market Report Highlights
- In 2022, the small molecule segment held the largest revenue share in the drug discovery services market, small molecules are highly valued for their small size, which enables them to easily pass through cell membranes and precisely target intracellular pathways. The use of small molecules in drug discovery has become increasingly popular due to their numerous advantages. For many years, the pharmaceutical industry has successfully created drugs based on small molecules, proving their effectiveness in treating a wide range of medical conditions.
- The pharmaceutical segment accounted for the largest market share during the forecast period. Companies allocate significant resources to research and development, driven by the desire to discover new drug candidates that can lead to groundbreaking treatments. Pharmaceutical and biotechnology firms excel in drug development and maintain strategic partnerships with contract research organizations and service providers. These collaborations enable them to leverage the specialized skills and resources of drug discovery service providers, resulting in more effective and efficient drug discovery processes.
- In 2022, North America dominated the largest market, North America's pharmaceutical and biotechnology sectors are thriving, playing a pivotal role in driving the demand for drug discovery services. The continent is also home to a robust and enduring research ecosystem comprising renowned research centers, prestigious academic institutions, and strong government support, all contributing to advancing scientific endeavors. The region's market leadership is further bolstered by its abundance of highly skilled researchers, scientists, and state-of-the-art technological capabilities.
- The Asia-Pacific region accounted for the fastest growth in the Drugs Discovery Services Market due to the expansion of the pharmaceutical sector owes its success to a variety of factors. Firstly, the rising incidence of chronic lifestyle-related illnesses within the region has driven companies to invest in developing treatments for these conditions. Secondly, the increasing number of biopharmaceutical enterprises in the area has created more opportunities for drug discovery services, thus fueling market growth.
- Lastly, the adoption of effective business strategies and regional collaborations is expected to exert a significant positive influence on the market. Moreover, government initiatives aimed at promoting research and development, coupled with favorable regulatory frameworks and tax incentives, have further bolstered market growth in this region.
- The global key market players include: Aurigene Discovery Technologies, Charles River Laboratories International Inc., Eurofins Scientific, Evotec, Frontage Labs, Galapagos NV, General Electric, Genscript, Laboratory Corporations of America Holdings, PPD Inc., Syngene International Limited, Thermo Fisher Scientific Inc., and WuXi AppTec.
Polaris Market Research has segmented the drug discovery services market report based on type, end-use, and region:
Drug Discovery Services, Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Small Molecules
- Large Molecules
Drug Discovery Services, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
- Pharmaceutical
- Biotechnology
- Academics
- Others
Drug Discovery Services, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM3920
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Drug Discovery Services Market Insights
- 4.1. Drug Discovery Services Market - Industry Snapshot
- 4.2. Drug Discovery Services Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing demand for novel therapies for numerous therapeutic processes
- 4.2.1.2. Rising expenditure in R&D in pharmaceutical and biotechnology sector
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Rigorous regulations governing the drug discovery and animal usage
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Drug Discovery Services Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Drug Discovery Services Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Drug Discovery Services, by Type, 2019-2032 (USD Billion)
- 5.3. Small Molecules
- 5.3.1. Global Drug Discovery Services Market, by Small Molecules, by Region, 2019-2032 (USD Billion)
- 5.4. Large Molecules
- 5.4.1. Global Drug Discovery Services Market, by Large Molecules, by Region, 2019-2032 (USD Billion)
6. Global Drug Discovery Services Market, by End-Use
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 6.3. Pharmaceutical
- 6.3.1. Global Drug Discovery Services Market, by Pharmaceutical, by Region, 2019-2032 (USD Billion)
- 6.4. Biotechnology
- 6.4.1. Global Drug Discovery Services Market, by Biotechnology, by Region, 2019-2032 (USD Billion)
- 6.5. Academics
- 6.5.1. Global Drug Discovery Services Market, by Academics, by Region, 2019-2032 (USD Billion)
- 6.6. Others
- 6.6.1. Global Drug Discovery Services Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Drug Discovery Services Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Drug Discovery Services Market Assessment, By Geography, 2019-2032 (USD Billion)
- 7.3. Drug Discovery Services Market - North America
- 7.3.1. North America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.3.2. North America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.3.3. Drug Discovery Services Market - U.S.
- 7.3.3.1. U.S.: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.3.3.2. U.S.: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.3.4. Drug Discovery Services Market - Canada
- 7.3.4.1. Canada: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.3.4.2. Canada: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.4. Drug Discovery Services Market - Europe
- 7.4.1. Europe: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.4.2. Europe: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.4.3. Drug Discovery Services Market - UK
- 7.4.3.1. UK: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.4.3.2. UK: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.4.4. Drug Discovery Services Market - France
- 7.4.4.1. France: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.4.4.2. France: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.4.5. Drug Discovery Services Market - Germany
- 7.4.5.1. Germany: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.4.5.2. Germany: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.4.6. Drug Discovery Services Market - Italy
- 7.4.6.1. Italy: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.4.6.2. Italy: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.4.7. Drug Discovery Services Market - Spain
- 7.4.7.1. Spain: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.4.7.2. Spain: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.4.8. Drug Discovery Services Market - Netherlands
- 7.4.8.1. Netherlands: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.4.8.2. Netherlands: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.4.9. Drug Discovery Services Market - Russia
- 7.4.9.1. Russia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.4.9.2. Russia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.5. Drug Discovery Services Market - Asia Pacific
- 7.5.1. Asia Pacific: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.5.2. Asia Pacific: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.5.3. Drug Discovery Services Market - China
- 7.5.3.1. China: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.5.3.2. China: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.5.4. Drug Discovery Services Market - India
- 7.5.4.1. India: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.5.4.2. India: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.5.5. Drug Discovery Services Market - Malaysia
- 7.5.5.1. Malaysia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.5.5.2. Malaysia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.5.6. Drug Discovery Services Market - Japan
- 7.5.6.1. Japan: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.5.6.2. Japan: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.5.7. Drug Discovery Services Market - Indonesia
- 7.5.7.1. Indonesia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.5.7.2. Indonesia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.5.8. Drug Discovery Services Market - South Korea
- 7.5.8.1. South Korea: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.5.8.2. South Korea: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.6. Drug Discovery Services Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.6.2. Middle East & Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.6.3. Drug Discovery Services Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.6.3.2. Saudi Arabia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.6.4. Drug Discovery Services Market - UAE
- 7.6.4.1. UAE: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.6.4.2. UAE: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.6.5. Drug Discovery Services Market - Israel
- 7.6.5.1. Israel: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.6.5.2. Israel: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.6.6. Drug Discovery Services Market - South Africa
- 7.6.6.1. South Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.6.6.2. South Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.7. Drug Discovery Services Market - Latin America
- 7.7.1. Latin America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.7.2. Latin America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.7.3. Drug Discovery Services Market - Mexico
- 7.7.3.1. Mexico: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.7.3.2. Mexico: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.7.4. Drug Discovery Services Market - Brazil
- 7.7.4.1. Brazil: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.7.4.2. Brazil: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- 7.7.5. Drug Discovery Services Market - Argentina
- 7.7.5.1. Argentina: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- 7.7.5.2. Argentina: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Aurigene Discovery Technologies
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Charles River Laboratories International Inc.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Eurofins Scientific
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Evotec
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Frontage Labs
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Galapagos NV
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. General Electric
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Genscript
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Laboratory Corporations of America Holdings
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. PPD Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Syngene International Limited
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Thermo Fisher Scientific Inc.
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. WuXi AppTec
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
Product Code: PM3920
List of Tables
- Table 1 Global Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 2 Global Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 3 Drug Discovery Services Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 4 North America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 5 North America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 6 U.S.: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 7 U.S.: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 8 Canada: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 9 Canada: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 10 Europe: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 11 Europe: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 12 UK: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 13 UK: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 14 France: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 15 France: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 16 Germany: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 17 Germany: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 18 Italy: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 19 Italy: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 20 Spain: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 21 Spain: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 22 Netherlands: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 23 Netherlands: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 24 Russia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 25 Russia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 26 Asia Pacific: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 27 Asia Pacific: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 28 China: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 29 China: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 30 India: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 31 India: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 32 Malaysia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 33 Malaysia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 34 Japan: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 35 Japan: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 36 Indonesia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 37 Indonesia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 38 South Korea: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 39 South Korea: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 40 Middle East & Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 41 Middle East & Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 42 Saudi Arabia: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 43 Saudi Arabia: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 44 UAE: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 45 UAE: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 46 Israel: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 47 Israel: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 48 South Africa: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 49 South Africa: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 50 Latin America: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 51 Latin America: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 52 Mexico: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 53 Mexico: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 54 Brazil: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 55 Brazil: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
- Table 56 Argentina: Drug Discovery Services Market, by End-Use, 2019-2032 (USD Billion)
- Table 57 Argentina: Drug Discovery Services Market, by Type, 2019-2032 (USD Billion)
List of Figures
- Figure 1 Global Drug Discovery Services Market, 2019-2032 (USD Billion)
- Figure 2 Integrated Ecosystem
- Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4 Market by Geography
- Figure 5 Porter's Five Forces
- Figure 6 Market by End-Use
- Figure 7 Global Drug Discovery Services Market, by End-Use, 2022 & 2032 (USD Billion)
- Figure 8 Market by Type
- Figure 9 Global Drug Discovery Services Market, by Type, 2022 & 2032 (USD Billion)
- Figure 10 Drug Discovery Services Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 11 Strategic Analysis - Drug Discovery Services Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.